Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Whitehawk Therapeutics (WHWK) Assets Average (2018 - 2025)

Historic Assets Average for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $173.9 million.

  • Whitehawk Therapeutics' Assets Average rose 8569.44% to $173.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $173.9 million, marking a year-over-year increase of 8569.44%. This contributed to the annual value of $101.4 million for FY2024, which is 3597.49% down from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Assets Average of $173.9 million as of Q3 2025, which was up 8569.44% from $207.4 million recorded in Q2 2025.
  • Over the past 5 years, Whitehawk Therapeutics' Assets Average peaked at $207.4 million during Q2 2025, and registered a low of $39.3 million during Q2 2021.
  • For the 5-year period, Whitehawk Therapeutics' Assets Average averaged around $133.7 million, with its median value being $145.4 million (2023).
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 24479.05% in 2022, then tumbled by 4265.81% in 2024.
  • Whitehawk Therapeutics' Assets Average (Quarter) stood at $163.3 million in 2021, then increased by 15.81% to $189.2 million in 2022, then decreased by 28.09% to $136.0 million in 2023, then crashed by 42.66% to $78.0 million in 2024, then surged by 122.95% to $173.9 million in 2025.
  • Its last three reported values are $173.9 million in Q3 2025, $207.4 million for Q2 2025, and $152.2 million during Q1 2025.